About the Product

Description


Epihype L Tablet containing Eperisone and Lornoxicam is used for the management of musculoskeletal pain and inflammation. It helps in relieving muscle stiffness, reducing swelling, and improving mobility.

Eperisone acts as a muscle relaxant to ease muscle tightness, while Lornoxicam provides strong anti-inflammatory and analgesic effects. This combination ensures effective relief from pain and inflammation.

The tablet is widely prescribed in orthopedic and general practice for conditions like back pain, joint pain, and muscle spasms, leading to consistent demand and repeat usage.

With increasing prevalence of musculoskeletal disorders and demand for effective combination therapies, this product offers strong business potential for retailers and distributors. Its fast action, steady prescription demand, and broad usage make it a fast-moving product that can drive consistent sales and growth in the pain management segment.

Some patients may experience nausea, dizziness, drowsiness, abdominal discomfort, or gastric irritation. Rarely, gastrointestinal bleeding, kidney function changes, or allergic reactions may occur and require medical attention.

Epihype L Tablet is indicated for the management of acute musculoskeletal pain, muscle spasms, back pain, cervical pain, and inflammatory conditions such as arthritis. It helps relieve pain, reduce stiffness, and enhance movement.

This medicine should be used under medical supervision. Patients with a history of gastrointestinal ulcers, kidney or liver disorders should use it cautiously. Avoid alcohol and do not exceed the recommended dose.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Epihype L Tablet in the PCD pharma franchise market?

Epihype L Tablet, containing Eperisone 50mg and Lornoxicam 4mg, has strong demand in the pain management and orthopedic segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners focusing on musculoskeletal care portfolios.

Why should medical distributors include Epihype L Tablet in their product range?

Medical distributors and agencies can benefit from the consistent market demand for medicines used in muscle spasm, acute pain, inflammation, cervical pain, and back pain. Epihype L Tablet helps strengthen a comprehensive pain and musculoskeletal care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Epihype L Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Epihype L Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Epihype L Tablet distribution?

Wholesalers and medical agencies benefit from attractive business margins, reliable product availability, professional support, and access to a trusted orthopedic and pain management product range when partnering for Epihype L Tablet distribution.

How can I become a distributor or franchise partner for Epihype L Tablet?

Medical distributors, stockists, and wholesalers interested in Epihype L Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.